Pfizer Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other companies in this sector in the United States: Novartis AG (2012 sales of $56.67 billion of which 57% was Pharmaceuticals), Johnson & Johnson ($67.22 billion of which 41% was Medical Devices & Diagnostics), and Bayer AG ($51.32 billion of which 29% was Material Science).

Sales Analysis. During the year ended December of 2012, sales at Pfizer Inc. were $58.99 billion. This is a decrease of 12.5% versus 2011, when the company's sales were $67.43 billion. Note that this company discontinued some operations during 2011, which could influence the sales figures. Contributing to the drop in overall sales was the 31.4% decline in Primary Care, from $22.67 billion to $15.56 billion. There were also decreases in sales in Specialty Care and Oncology (down 6.7% to $15.46 billion) . However, these declines were partially offset by the increase in sales of Animal Health and Consumer Healthcare (up 3.7% to $7.51 billion) .
Business Description